Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty

NCT00567411 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

43

Enrollment

FED

Sponsor class

Conditions

Glaucoma
Ocular Hypertension

Interventions

DRUG: brimonidine 0.1%
DRUG: Apraclonidine 0.5%

Sponsor

Walter Reed Army Medical Center